By Frank Prenesti
Date: Monday 22 Sep 2025
(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.
SEP cashes in as US giant Amgen buys cancer drug... | 26-Jan-2011 | The Scotsman |
Amgen Buys a Cancer Drug Maker | 25-Jan-2011 | New York Times |
Tech Ticker | 16-Dec-2010 | BayArea.com |
Amgen drug delayed spread of prostate cancer to ... | 15-Dec-2010 | LA Times |
Business Briefing | 24-Dec-2009 | LA Times |
Currency | US Dollars |
Share Price | $ 297.89 |
Change Today | $ 0.49 |
% Change | 0.16 % |
52 Week High | $328.35 |
52 Week Low | $258.59 |
Volume | 2,518,707 |
Shares Issued | 536.90m |
Market Cap | $159,937m |
RiskGrade | 100 |
Strong Buy | 6 |
Buy | 7 |
Neutral | 15 |
Sell | 2 |
Strong Sell | 1 |
Total | 31 |
Time | Volume / Share Price |
15:59 | 320 @ $297.89 |
15:59 | 121 @ $297.89 |
15:59 | 100 @ $297.91 |
15:59 | 100 @ $297.86 |
15:59 | 100 @ $297.86 |
You are here: research